2 terminated, 1 unknown. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Terminated 2, Unknown 1 |
| Phase 2 | 1 | Terminated 1 |
Follow SHR-1701: new trials by email Literature Review of SHR-1701 trials Research Report on SHR-1701
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of SHR-1701 Plus Platinum-containing Chemotherapy With or Without BP102 (Bevacizumab) as First-line Treatment in Cervical Cancer SHR-1701 + paclitaxel + cisplatin/carboplatin + BP102, SHR-1701 + paclitaxel + cisplatin/carboplatin± BP102, Placebo + paclitaxel + cisplatin/carboplatin ± BP102 - Cervical Cancer | Phase 3 | Terminated | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 31 | 2022-02-26 | 2025-04-15 |
| Clinical Study of SHR-1701 Plus Chemotherapy as Perioperative Treatment in Subjects With Gastric Cancer SHR-1701 injection, Placebo - Perioperative Treatment in Subjects With Locally Advanced Resectable Gastric Cancer or Gastroesophageal Junction Cancer | Phase 2 / Phase 3 | Terminated | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 81 | 2022-01-26 | 2025-08-20 |
| A Study of SHR-1701 Plus Bevacizumab and Chemotherapy in Non-Small-Cell-Lung-Cancer SHR-1701 + Pemetrexed Disodium + cisplatin/carboplatin + bevacizumab, Placebo + SHR-1701 + Pemetrexed Disodium+ cisplatin/carboplatin, Placebo 1 + Placebo 2 +Pemetrexed Disodium + cisplatin/carboplatin - Advanced or Metastatic Non-squamous Non-small-cell Lung Cancer | Phase 3 | Unknown | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 561 | 2021-12-30 | 2021-11-24 |
Uterine Cervical Neoplasms (1)
Suzhou Suncadia Biopharmaceuticals Co., Ltd. (3)
China (2)